1 |
Wang Q, Wang X, Wang J, et al. Phenotypic and genotypic characterization of carbapenem-resistant enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012-2016) [J]. Clin Infect Dis, 2018, 67(suppl 2): S196-S205.
|
2 |
Gu D, Dong N, Zheng Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study [J]. Lancet Infect Dis, 2018, 18(1): 37-46.
|
3 |
CLSI. Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement [J]. CLSI document M100-S25. Wayne, PA: 2015, 35(3).
|
4 |
Ye M, Tu J, Jiang J, et al. Clinical and genomic analysis of liver abscess-causing klebsiella pneumoniae identifies new liver abscess-associated virulence genes [J]. Front Cell Infect Microbiol, 2016, 6: 165.
|
5 |
覃金球,丘岳,郭世辉, 等. 肺炎克雷伯菌的分布及耐药性分析 [J]. 中国感染与化疗杂志, 2017, 17(3): 269-272.
|
6 |
翟如波,张昊,吴秋梅, 等. 2008-2010年医院感染肺炎克雷伯菌临床分布及耐药性变迁分析 [J/CD]. 中华临床医师杂志(电子版), 2011, 5(22): 6785-6787.
|
7 |
陈济超,陈凯丽,梁国威, 等. 肺炎克雷伯杆菌101株临床分布与耐药性分析 [J/CD]. 中华临床医师杂志(电子版), 2013, 7(6): 2443-2446.
|
8 |
邱星安. 肺炎克雷伯菌的耐药趋势及耐药机制的研究进展 [J]. 中国现代药物应用, 2011, 5(5): 236-238.
|
9 |
Doi Y, Paterson DL. Carbapenemase-producing enterobacteriaceae [J]. Semin Respir Crit Care Med, 2015, 36(1): 74-84.
|
10 |
Zhang R, Liu L, Zhou H, et al. Nationwide surveillance of clinical carbapenem-resistant enterobacteriaceae (CRE) strains in China [J]. EBioMedicine, 2017, 19: 98-106.
|
11 |
Yang Q, Wang H, Sun H, et al. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China [J]. Antimicrob Agents Chemother, 2010, 54(1): 573-577.
|
12 |
Hao Z, Duan J, Liu L, et al. Prevalence of community-acquired, hypervirulent Klebsiella pneumoniae isolates in Wenzhou, China [J]. Microb Drug Resist, 2020, 26(1): 21-27.
|
13 |
田李均,王晓丽,刘嘉琳, 等. 医院内高黏液性肺炎克雷伯菌的流行分布、毒力基因及临床特征分析 [J]. 上海交通大学学报(医学版), 2017, 37(1): 43-48.
URL
|
14 |
Liu YM, Li BB, Zhang YY, et al. Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China [J]. Antimicrob Agents Chemother, 2014, 58(9): 5379-5385.
|
15 |
Zhang Y, Zhao C, Wang Q, et al. High prevalence of hypervirulent Klebsiella pneumoniae infection in China: geographic distribution, clinical characteristics, and antimicrobial resistance [J]. Antimicrob Agents Chemother, 2016, 60(10): 6115-6120.
|
16 |
Liu BT, Su WQ. Whole genome sequencing of NDM-1-producing serotype K1 ST23 hypervirulent Klebsiella pneumoniae in China [J]. J Med Microbiol, 2019, 68(6): 866-873.
|
17 |
杜芳玲,梅艳芳,万腊根, 等. 高黏液型肺炎克雷伯菌荚膜血清分型及碳青霉烯类耐药机制研究 [J]. 中国感染与化疗杂志, 2018, 18(3): 278-285.
|
18 |
Yuan J, Chen C, Cui J, et al. Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae [J]. Cell Metab, 2019, 30(4): 675-688.e7.
|